학술논문

Two of a kind: mass and molar immunoassay-based lipoprotein (a) concentrations are similarly prognostic for MACE risk and predictive of alirocumab benefit in ODYSSEY OUTCOMES
Document Type
Journal
Source
EUROPEAN HEART JOURNAL; NOV 2023, 44 3p. Supplement: 2
Subject
Language
English
ISSN
15229645